Hao Cui

586 total citations
28 papers, 305 citations indexed

About

Hao Cui is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Hao Cui has authored 28 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Hao Cui's work include Liver Disease Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune cells in cancer (5 papers). Hao Cui is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune cells in cancer (5 papers). Hao Cui collaborates with scholars based in China, Germany and Denmark. Hao Cui's co-authors include Yuyue Zhao, Guang‐Tao Yu, Guowang Cheng, Lushan Xiao, Lang Rao, Limin Ma, Yuanwei Pan, Li Liu, Qian‐Fang Meng and Zhou Lan and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Journal of Controlled Release.

In The Last Decade

Hao Cui

28 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Cui China 10 83 81 76 72 43 28 305
Carmen Chan China 9 48 0.6× 72 0.9× 70 0.9× 112 1.6× 41 1.0× 13 352
Fei Zhou China 5 89 1.1× 48 0.6× 162 2.1× 108 1.5× 91 2.1× 8 317
Guofeng Ji China 10 160 1.9× 145 1.8× 81 1.1× 135 1.9× 25 0.6× 23 371
Manzhi Zhao China 11 34 0.4× 68 0.8× 70 0.9× 82 1.1× 31 0.7× 22 254
Zhuoming Zhou China 10 150 1.8× 29 0.4× 39 0.5× 33 0.5× 78 1.8× 37 354
Änne Schmitz Germany 11 75 0.9× 105 1.3× 57 0.8× 22 0.3× 51 1.2× 24 380
Jian Wan China 10 28 0.3× 54 0.7× 63 0.8× 25 0.3× 81 1.9× 27 277
Kazuya Sakata Japan 12 58 0.7× 154 1.9× 149 2.0× 44 0.6× 77 1.8× 39 549
Abigail Zabron United Kingdom 8 71 0.9× 51 0.6× 119 1.6× 12 0.2× 46 1.1× 14 319
Yaowei Bai China 10 51 0.6× 45 0.6× 40 0.5× 20 0.3× 105 2.4× 44 296

Countries citing papers authored by Hao Cui

Since Specialization
Citations

This map shows the geographic impact of Hao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cui more than expected).

Fields of papers citing papers by Hao Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cui. The network helps show where Hao Cui may publish in the future.

Co-authorship network of co-authors of Hao Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Cui. A scholar is included among the top collaborators of Hao Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Cui. Hao Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Lushan, Lin Zeng, Chang Hong, et al.. (2025). Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease. Advanced Science. 12(33). e10527–e10527. 2 indexed citations
2.
Chen, Hao, Hao Cui, Wei Liu, et al.. (2024). Manganese drives ferroptosis of cancer cells via YAP / TAZ phase separation activated ACSL4 in OSCC. Oral Diseases. 30(8). 4898–4908. 7 indexed citations
5.
Cui, Hao, et al.. (2023). Targeting intracellular and extracellular receptors with nano-to-macroscale biomaterials to activate immune cells. Journal of Controlled Release. 357. 52–66. 12 indexed citations
6.
Li, Yanfang, et al.. (2023). Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19. Epidemiology and Infection. 151. e34–e34. 3 indexed citations
7.
Zeng, Lin, Chang Hong, Hao Cui, et al.. (2023). Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants. Clinical Endocrinology. 100(2). 116–123. 5 indexed citations
8.
Lan, Zhou, et al.. (2023). PFC@O2 Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC. Journal of Clinical Medicine. 12(2). 560–560. 8 indexed citations
9.
Cui, Hao, Qi Ye, Chunyue Guo, & Naijun Tang. (2023). The effect of PM2.5 exposure on the mortality of patients with hepatocellular carcinoma in Tianjin, China. Environmental Science and Pollution Research. 30(32). 78632–78640. 4 indexed citations
10.
Xiao, Lushan, Qimei Li, Chang Hong, et al.. (2023). Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study. Cancer Immunology Immunotherapy. 72(7). 2299–2308. 4 indexed citations
11.
Cui, Hao, et al.. (2023). Biomaterials-mediated ligation of immune cell surface receptors for immunoengineering. Immuno-Oncology Technology. 21. 100695–100695. 1 indexed citations
12.
Lan, Zhou, et al.. (2022). CD24 blockade promotes anti‐tumor immunity in oral squamous cell carcinoma. Oral Diseases. 30(2). 163–171. 11 indexed citations
13.
Liu, Yuhua, Hao Cui, Xinxin Xu, & Wenquan Liang. (2022). Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database. World Journal of Surgical Oncology. 20(1). 325–325. 4 indexed citations
14.
15.
Cui, Hao, et al.. (2022). CT images-based 3D convolutional neural network to predict early recurrence of solitary hepatocellular carcinoma after radical hepatectomy. SHILAP Revista de lepidopterología. 28(6). 524–531. 2 indexed citations
16.
Zhao, Yuyue, Yuanwei Pan, Zhou Lan, et al.. (2022). Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy. Bioactive Materials. 19. 237–250. 99 indexed citations
17.
Cui, Hao, Chang Hong, Lin Zeng, et al.. (2022). Breakfast consumption frequency is associated with dyslipidemia: a retrospective cohort study of a working population. Lipids in Health and Disease. 21(1). 33–33. 7 indexed citations
18.
Cui, Hao, et al.. (2022). STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma. Cancer Immunology Immunotherapy. 72(5). 1315–1326. 10 indexed citations
20.
Xiao, Lushan, Qimei Li, Hao Cui, et al.. (2021). Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors. Annals of Palliative Medicine. 10(11). 11244–11254. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026